ROIVANT SCIENCES LTD's ticker is and the CUSIP is G76279101. A total of 72 filers reported holding ROIVANT SCIENCES LTD in Q2 2022. The put-call ratio across all filers is 0.72 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $51,081,026 | +0.3% | 4,832,642 | 0.0% | 15.77% | +18.9% |
| Q1 2024 | $50,936,047 | -6.1% | 4,832,642 | 0.0% | 13.26% | +105.2% |
| Q4 2023 | $54,270,570 | -3.9% | 4,832,642 | 0.0% | 6.46% | +26.6% |
| Q3 2023 | $56,445,259 | +15.9% | 4,832,642 | 0.0% | 5.10% | +18.7% |
| Q2 2023 | $48,713,031 | +36.6% | 4,832,642 | 0.0% | 4.30% | -22.1% |
| Q1 2023 | $35,664,898 | -7.6% | 4,832,642 | 0.0% | 5.51% | +11.3% |
| Q4 2022 | $38,612,810 | +148.1% | 4,832,642 | 0.0% | 4.95% | +256.8% |
| Q3 2022 | $15,561,000 | -20.9% | 4,832,642 | 0.0% | 1.39% | -29.4% |
| Q2 2022 | $19,669,000 | -17.6% | 4,832,642 | 0.0% | 1.97% | +21.3% |
| Q1 2022 | $23,873,000 | – | 4,832,642 | – | 1.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 66,719,779 | $705,228,064 | 66.32% |
| Patient Square Capital LP | 12,228,465 | $129,254,875 | 59.99% |
| Atalaya Capital Management LP | 1,714,843 | $18,125,891 | 40.31% |
| Two Seas Capital LP | 10,318,764 | $109,069,335 | 17.73% |
| Anchorage Capital Group, L.L.C. | 4,832,642 | $51,081,026 | 15.77% |
| Whitefort Capital Management, LP | 2,391,000 | $25,272,870 | 15.58% |
| STEMPOINT CAPITAL LP | 2,712,741 | $28,673,672 | 8.43% |
| Tejara Capital Ltd | 2,183,943 | $23,084,278 | 8.39% |
| Tyro Capital Management LLC | 1,744,327 | $18,437,536 | 8.36% |
| ADAR1 Capital Management, LLC | 4,150,009 | $43,865,595 | 8.28% |